Kenya: Kenya on Track in HPV Vaccination Despite Setbacks


[Nation] Kenya is on course in the immunisation of 800,000 girls against cervical cancer, Health Cabinet Secretary Sicily Kariuki has said, and allayed fears about the safety of the vaccine.

Related Links:

Publication date: Available online 12 November 2019Source: Preventive MedicineAuthor(s): Michelle I. Silver, Sarah KobrinAbstractThe human papillomavirus (HPV) vaccine is a powerful tool in cancer prevention. In combination with cervical cancer screening programs, this vaccine has the potential to nearly eliminate death from cervical cancer. However, this remarkable public health success can only be realized if vaccines reach those most at risk—unscreened women. Vaccinating only those already well-screened would have little impact on cervical cancer mortality, exacerbate disparities, and be a striking public health f…

Source: Preventive MedicineCategory: International Medicine & Public Health Source Type: research

(Elsevier) A new study in The American Journal of Pathology, published by Elsevier, reports that medroxyprogesterone acetate (MPA), the active ingredient in the common contraceptive injection Depo-Provera, was effective in preventing the development of cervical cancer in mice with precancerous lesions. The drug also decreased existing precancerous lesions. If proven effective clinically, MPA may be a boon to women who do not have access to human papillomavirus (HPV) vaccines.

ConclusionsThe cancer burden attributable to HPV in China is substantial. HPV vaccination and cervical screening should be prioritized.

Source: Cancer MedicineCategory: Cancer & Oncology Authors: Tags: ORIGINAL RESEARCH Source Type: research

ConclusionWhile educational intervention can promote a father ’s positive attitude towards HPV vaccination, it is ineffective at promoting a positive intention to follow through to inoculate their daughters or improving their willingness to assist in the decision-making process.

This study firstly determined the knowledge of risk factors and prevention of cervical cancer. Secondly, it checked an association between mothers’ screening practice and student’s knowledge. A descriptive, cross sectional study was conducted among 253 pairs of high school students and their mothers. Knowledge on cervical cancer was significantly lower among students and mothers. While cancer screening tests, maintenance of hygiene were considered as major preventive measures for cervical cancer, human papilloma vaccine was the least considered preventive measure. Students who were female, attended disc…

Did you know that a viral infection can lead to a number of different types of cancer? If that comes as a surprise to you, you’re not alone. In fact, according to a new study, many people have no idea that a common viral infection called human papilloma virus (HPV) can cause cancer of the genitals, anus, mouth, and throat, as well as cervical cancer.
Viral infections and cancer
The connection between certain viral infections and cancer has been recognized for many years. Some of the most well-established examples include hepatitis C, human immunodeficiency virus (HIV), and human papillomavirus (HPV). One thing these …

Source: Harvard Health BlogCategory: Consumer Health News Authors: Tags: Adolescent health Cancer Infectious diseases Men’s Health Sexual Conditions Vaccines Women’s Health Source Type: blogs

Authors: Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A
Viral infections contribute as a cause of 15-20% of all human cancers. Infection by oncogenic viruses can promote different stages of carcinogenesis. Among many types of HPV, around 15 are linked to cancer. In spite of effective screening methods, cervical cancer continues to be a major public health problem. There are wide differences in cervical cancer incidence and mortality by geographic region. In addition, the age-specific HPV prevalence varies widely across different populations and showed two peaks of HPV positivity in younger an…

Source: Journal of OncologyCategory: Cancer & Oncology Tags: J Oncol Source Type: research

Publication date: Available online 7 November 2019Source: Journal of Cancer PolicyAuthor(s): Hasan Aykut TuncerAbstractObjectiveThe success of any cancer screening policy is known to be closely related to the population’s participation in screening programs and baseline knowledge about cancer and the screening program. We investigated popular awareness, knowledge and attitudes towards cervical cancer, HPV and the screening program after HPV-based screening began in Turkey.MethodsA gynecologist administered questionnaire was conducted to 429 women aged 30 to 65 years in a tertiary care settings. Sociodemographic chara…

(Michigan Medicine – University of Michigan) Virtually all cervical cancers are caused by HPV, and much of the attention in recent years has focused on preventing infections in younger women through HPV vaccination.But this may be taking attention off of another population that stands to benefit greatly from regular screening: women over 45.Despite the fact that half of cervical cancers are diagnosed after age 49, participation in preventive screening steadily declines between ages 45 and 65, according to a first-of-its-kind analysis of three large national surveys.

The objective of this work was to provide an update information on HPV age/genotype distribution by retrospectively analyzing a cohort of women living in the metropolitan area of Naples.MethodsFrom January 2011 to December 2017, cervical scrape specimens from 1265 women, with abnormal cytological indication, were tested for HPV DNA. The presence and the viral genotypes were assessed by the Linear Array HPV genotyping test for the detection of 37 anogenital HPV-DNA genotypes.ResultsThe overall prevalence of HPV infections was of 44.5% (95% CI 41.77–47.24). Among HR-HPV types, HPV-16 was the most common identified geno…

Source: Cancer EpidemiologyCategory: Cancer & Oncology Source Type: research

Source link